Previous 10 | Next 10 |
2023-12-18 12:44:04 ET Summary ZBH reported strong 3Q23 performance and has provided a positive business outlook. The company's new innovations and increasing presence in ambulatory surgery centers (ASCs) are driving growth. GLP-1 should be a tailwind for ZBH, extending its lo...
2023-12-17 17:48:14 ET More on Abbott Laboratories, Glaukos, etc. Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio Zimmer Biomet: Still Many Questions After A Solid Year So Far Abbott Laboratories: One Of The Safest Dividend Growth Stocks O...
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2023 PR Newswire WARSAW, Ind. , Dec. 14, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has ap...
2023-12-06 13:16:08 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-12-03 17:58:12 ET More on Novo Nordisk, Stryker, etc. Why Stryker Is An Awesome Healthcare Compounder Stryker Corporation (SYK) 6th Annual Evercore ISI HealthCONx Conference (Transcript) Novo Nordisk: Plenty More Room To Run Despite Its Hefty Valuation N...
2023-11-26 05:58:17 ET Summary Zimmer Biomet has seen a strong operating performance despite years of stagnation, making its shares compelling. The company's valuation has become more reasonable, with revenues trending at around $7.3 billion and adjusted earnings reported at $7.50...
2023-11-22 03:55:00 ET Summary Matrix Asset Advisors is a Value-Driven asset management company. Our investment philosophy and process has allowed us to build a cohesive team of key investment professionals, enabling us to be both opportunistic and responsive. The S&P 500 decl...
2023-11-19 12:00:00 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Perfectly Priced Healthcare Giant Novo Nordisk A/S (NVO) Novo Nordisk R&D Investor Event (Transcript) Eli Lilly: Favorable Developments Continue Regarding Anti-Obesity Drug Franchise ...
Zimmer Biomet to Present at the 2023 Piper Sandler Healthcare Conference PR Newswire WARSAW, Ind. , Nov. 16, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biom...
2023-11-13 12:13:48 ET More on DexCom, Novo, etc. Novo Nordisk A/S (NVO) Novo Nordisk R&D Investor Event (Transcript) Eli Lilly: Favorable Developments Continue Regarding Anti-Obesity Drug Franchise Eli Lilly and Company (LLY) Presents at UBS Biopharma 2023 Confe...
News, Short Squeeze, Breakout and More Instantly...
Zimmer Biomet Holdings Inc. Company Name:
ZBH Stock Symbol:
NYSE Market:
Zimmer Biomet Holdings Inc. Website:
2024-07-15 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results PR Newswire WARSAW, Ind. , July 8, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will ...
Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors PR Newswire WARSAW, Ind. , June 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdika...